Chicago Partners Investment Group’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-17,028
| Closed | -$152K | – | 666 |
|
|
2023
Q2 | $152K | Buy |
17,028
+5,710
| +50% | +$51K | 0.01% | 652 |
|
|
2023
Q1 | $115K | Sell |
11,318
-3,207
| -22% | -$32.6K | 0.01% | 640 |
|
|
2022
Q4 | $196K | Buy |
14,525
+255
| +2% | +$3.44K | 0.01% | 594 |
|
|
2022
Q3 | $210K | Buy |
14,270
+2,644
| +23% | +$38.9K | 0.02% | 524 |
|
|
2022
Q2 | $149K | Buy |
11,626
+596
| +5% | +$7.64K | 0.01% | 560 |
|
|
2022
Q1 | $106K | Buy |
11,030
+470
| +4% | +$4.52K | 0.01% | 539 |
|
|
2021
Q4 | $153K | Buy |
10,560
+1,237
| +13% | +$17.9K | 0.01% | 536 |
|
|
2021
Q3 | $212K | Buy |
+9,323
| New | +$212K | 0.01% | 536 |
|